HUP0500423A2 - Transzgenikus úton előállított fúziós fehérjék - Google Patents
Transzgenikus úton előállított fúziós fehérjékInfo
- Publication number
- HUP0500423A2 HUP0500423A2 HU0500423A HUP0500423A HUP0500423A2 HU P0500423 A2 HUP0500423 A2 HU P0500423A2 HU 0500423 A HU0500423 A HU 0500423A HU P0500423 A HUP0500423 A HU P0500423A HU P0500423 A2 HUP0500423 A2 HU P0500423A2
- Authority
- HU
- Hungary
- Prior art keywords
- fusion protein
- expression
- transgene
- subject
- fusion proteins
- Prior art date
Links
- 108020001507 fusion proteins Proteins 0.000 title abstract 7
- 102000037865 fusion proteins Human genes 0.000 title abstract 7
- 230000009261 transgenic effect Effects 0.000 abstract 3
- 108700019146 Transgenes Proteins 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 101710160107 Outer membrane protein A Proteins 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2881—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD71
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/30—Animal model comprising expression system for selective cell killing, e.g. toxins, enzyme dependent prodrug therapy using ganciclovir
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Environmental Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Animal Husbandry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39861099A | 1999-09-17 | 1999-09-17 | |
PCT/US2000/025560 WO2001019846A1 (en) | 1999-09-17 | 2000-09-18 | Transgenically produced fusion proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP0500423A2 true HUP0500423A2 (hu) | 2005-08-29 |
Family
ID=23576046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0500423A HUP0500423A2 (hu) | 1999-09-17 | 2000-09-18 | Transzgenikus úton előállított fúziós fehérjék |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1220864A4 (pt) |
JP (1) | JP2003509040A (pt) |
KR (1) | KR20020073127A (pt) |
CN (1) | CN1414970A (pt) |
AU (1) | AU782840B2 (pt) |
BR (1) | BR0014527A (pt) |
CA (1) | CA2382725A1 (pt) |
HU (1) | HUP0500423A2 (pt) |
IL (1) | IL148550A0 (pt) |
MX (1) | MXPA02002769A (pt) |
NO (1) | NO20021275L (pt) |
NZ (1) | NZ517666A (pt) |
RU (1) | RU2002110121A (pt) |
WO (1) | WO2001019846A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6800462B2 (en) * | 2001-09-10 | 2004-10-05 | Abgenomics Corporation | Production of recombinant proteins in vivo and use for generating antibodies |
US20030049694A1 (en) * | 2001-09-10 | 2003-03-13 | Chung-Hsiun Wu | Production of fusion proteins and use for identifying binding molecules |
KR100603016B1 (ko) * | 2004-07-21 | 2006-07-24 | 황호연 | 라벨용 포장필름의 제조방법, 상기 제조방법으로 제조된라벨용 포장필름 및 상기 포장필름의 사용방법 |
WO2007122511A2 (en) * | 2006-04-21 | 2007-11-01 | Mab-Factory Gmbh | Antibody-rnase-conjugate |
KR100952960B1 (ko) * | 2007-12-31 | 2010-04-15 | 전남대학교산학협력단 | 돼지 β-카제인 게놈 DNA를 이용하여 생리활성물질을생산하기 위한 넉-인 벡터 및 이를 이용하여생리활성물질을 생산하는 방법 |
WO2010036978A2 (en) | 2008-09-25 | 2010-04-01 | Transgenrx, Inc. | Novel vectors for production of growth hormone |
WO2010036976A2 (en) | 2008-09-25 | 2010-04-01 | Transgenrx, Inc. | Novel vectors for production of antibodies |
US9150881B2 (en) | 2009-04-09 | 2015-10-06 | Proteovec Holding, L.L.C. | Production of proteins using transposon-based vectors |
WO2011060489A1 (en) * | 2009-11-18 | 2011-05-26 | Murray Goulburn Co-Operative Co. Limited | Transgenic non-human animals |
CN102981002B (zh) * | 2012-11-29 | 2014-08-06 | 同昕生物技术(北京)有限公司 | 采用标签蛋白人源化嵌合抗体作为阳性对照物的间接免疫检测方法及试剂盒 |
CN104862318A (zh) * | 2014-02-25 | 2015-08-26 | 南京杰蒙生物技术有限公司 | 利用转基因动物乳腺生物反应器生产单克隆抗体的方法 |
SG11202005510SA (en) * | 2017-12-22 | 2020-07-29 | Hanmi Pharmaceutical Co Ltd | Therapeutic enzyme fusion protein having a novel structure and use thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0832981A1 (en) * | 1987-02-17 | 1998-04-01 | Pharming B.V. | DNA sequences to target proteins to the mammary gland for efficient secretion |
US5840840A (en) * | 1990-04-17 | 1998-11-24 | The United States Of America As Represented By The Department Of Health And Human Services | Selective RNase cytotoxic reagents |
US5206161A (en) * | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
IL111748A0 (en) * | 1993-12-03 | 1995-01-24 | Zeneca Ltd | Proteins |
GB9406974D0 (en) * | 1994-04-08 | 1994-06-01 | Pharmaceutical Proteins Ltd | Transgenic production |
US5959171A (en) * | 1994-08-17 | 1999-09-28 | Pharming B.V. | Method for the production of biologically active polypeptides in a mammal's |
US5880327A (en) * | 1994-09-21 | 1999-03-09 | American National Red Cross | Transgenic mammals expressing human coagulation factor VIII |
EP0806964B1 (en) * | 1994-12-23 | 2002-08-14 | AstraZeneca AB | Chemical compounds |
IL116696A (en) * | 1995-01-25 | 1999-08-17 | Bio Technology General Corp | Production of enzymatically active recombinant carboxypeptidase b |
KR19990036383A (ko) * | 1995-08-16 | 1999-05-25 | 크로우 캐씨 엘 | 화학적 화합물 |
AU744160B2 (en) * | 1996-10-25 | 2002-02-14 | Cell Genesys, Inc. | Targeted cytolysis of cancer cells |
-
2000
- 2000-09-18 JP JP2001523623A patent/JP2003509040A/ja not_active Withdrawn
- 2000-09-18 EP EP00963586A patent/EP1220864A4/en not_active Withdrawn
- 2000-09-18 AU AU38832/01A patent/AU782840B2/en not_active Ceased
- 2000-09-18 CN CN00814423A patent/CN1414970A/zh active Pending
- 2000-09-18 KR KR1020027003529A patent/KR20020073127A/ko not_active Application Discontinuation
- 2000-09-18 HU HU0500423A patent/HUP0500423A2/hu unknown
- 2000-09-18 IL IL14855000A patent/IL148550A0/xx unknown
- 2000-09-18 RU RU2002110121/13A patent/RU2002110121A/ru not_active Application Discontinuation
- 2000-09-18 MX MXPA02002769A patent/MXPA02002769A/es unknown
- 2000-09-18 WO PCT/US2000/025560 patent/WO2001019846A1/en active IP Right Grant
- 2000-09-18 BR BR0014527-0A patent/BR0014527A/pt not_active Expired - Fee Related
- 2000-09-18 CA CA002382725A patent/CA2382725A1/en not_active Abandoned
- 2000-09-18 NZ NZ517666A patent/NZ517666A/en unknown
-
2002
- 2002-03-14 NO NO20021275A patent/NO20021275L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU782840B2 (en) | 2005-09-01 |
KR20020073127A (ko) | 2002-09-19 |
WO2001019846A8 (en) | 2001-04-19 |
MXPA02002769A (es) | 2005-07-01 |
RU2002110121A (ru) | 2004-03-10 |
EP1220864A4 (en) | 2003-05-21 |
NO20021275D0 (no) | 2002-03-14 |
WO2001019846A9 (en) | 2002-10-03 |
AU3883201A (en) | 2001-04-17 |
BR0014527A (pt) | 2002-06-18 |
CA2382725A1 (en) | 2001-03-22 |
CN1414970A (zh) | 2003-04-30 |
NZ517666A (en) | 2004-02-27 |
IL148550A0 (en) | 2002-09-12 |
WO2001019846A1 (en) | 2001-03-22 |
EP1220864A1 (en) | 2002-07-10 |
NO20021275L (no) | 2002-05-10 |
JP2003509040A (ja) | 2003-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Doxsey | Re-evaluating centrosome function | |
Souza | Basic cell biology of Trypanosoma cruzi | |
Einarsson et al. | Coordinated changes in gene expression throughout encystation of Giardia intestinalis | |
HUP0500423A2 (hu) | Transzgenikus úton előállított fúziós fehérjék | |
CN110418647A (zh) | Rna指导的核酸修饰酶及其使用方法 | |
Goldman | Evolution of immune functions of the mammary gland and protection of the infant | |
CN110023494A (zh) | Rna指导的核酸修饰酶及其使用方法 | |
NO820090L (no) | Fremgangsmaate for fremstilling og behandling av renninderivater | |
HUP0105303A2 (en) | Her-2/neu fusion proteins | |
AU2002361327A1 (en) | Exogenous protein expression system in an avian system | |
CN105308183A (zh) | 改变胆固醇水平的组合物和方法 | |
ATE355826T1 (de) | Verfahren zur verkapselung von nukleinsäuren in lipiddoppelschichten | |
WO2002086071A3 (en) | Cancer-testis antigens | |
Panno | Animal cloning: the science of nuclear transfer | |
WO2002078526A3 (en) | Cancer-testis antigens | |
WO2000077239A3 (en) | Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses | |
DE60036487D1 (de) | Polymorphismus im humanen mdr-1 gen und dessen verwendung | |
Panno | Aging: Theories and potential therapies | |
Walker | Parasitic adaptations in the transmission of Theileria by ticks—a review | |
PT994901E (pt) | Processo de extraccao, identificacao e utilizacao dos principios activos das conchas de moluscos marinhos | |
Barrias et al. | Life Cycle of Pathogenic Protists: Trypanosoma cruzi | |
Eisenbarth et al. | Inhibition of chondromucoprotein synthesis: an extraneuronal effect of nerve growth factor. | |
ATE276364T1 (de) | Biologisches material zur herstellung pharmazeutischer zusammensetzungen zur behandlung von säugetieren | |
RU2601126C2 (ru) | Способ получения биологически активных пептидов | |
HUP9800520A2 (hu) | Génexpresszió emlős sejtekben |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |